CLEAR GUIDE SCENERGY™ Device for Transperineal Interventions
Clear Guide Medical proudly announces the FDA clearance for the CLEAR GUIDE SCENERGY computer aided instrument guidance system, alongside the new TP Access Tool with SteriGRID™.
Healthcare Press Releases
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly. Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Healthcare industry.
— To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology', This email address is being protected from spambots. You need JavaScript enabled to view it.
— To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology', This email address is being protected from spambots. You need JavaScript enabled to view it.
Aerin Medical Announces Positive Two-year Outcomes from the VATRAC Trial of VivAer
Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced that Rhinology Journal has published positive two-year outcomes from the VATRAC trial.
ViiV Healthcare announces new packaging option now available in the U.S. for Dovato
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, announced Dovato (dolutegravir/ lamivudine) is now available in a blister pack in the U.S.
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).
PrepMD's online cardiac healthcare training solutions now approved for CEUs
PrepMD, the leading cardiac healthcare solutions provider, announced the accreditation of their online healthcare training programs for Nursing Continuing Education Units (CEUs).
Providence Swedish Radiosurgery Center in Seattle acquires second Accuray CyberKnife® System for precise radiation treatments in 1-5 sessions
Accuray Incorporated announced that the Providence Swedish Radiosurgery Center in Seattle, Washington is enhancing its cancer treatment capabilities with the purchase of the latest generation CyberKnife® S7™ System, the hospital's second CyberKnife radiation delivery device purchase.
Olympus announces full market availability of redesigned energy platform
Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced full market availability of its new ESG-410™ Surgical Energy Platform for conventional monopolar and bipolar, advanced energy applications now including ultrasonic dissection and hybrid energy.
IlluminOss celebrates 10,000 light-cured implants used by surgeons to strengthen fragile bone and heal geriatric fractures
IlluminOss Medical announces it has reached the important benchmark of having placed 10,000 of its patient conforming implants designed for the treatment of geriatric fractures.
BD and Hamilton collaborate to standardize single-cell multiomics experiments with robotics
BD a leading global medical technology company, announced a collaboration agreement with Hamilton, a leading global manufacturer of laboratory automation technology, to develop automated applications together with robotics-compatible reagent kits to enable greater standardization and reduced human error when conducting large-scale single-cell multiomics experiments.
Single Pass and Mermaid Medical Group sign exclusive US distribution deal for Biopsy Closure Device
Single Pass, a leading provider of innovative medical devices, is pleased to announce an exclusive distribution agreement with Mermaid Medical Group, a renowned global medical technology company.